文献速递血液透析通路

血液透析血管通路的维护与通路功能障碍的预防:综述

Maintenance of Hemodialysis Vascular Access and Prevention of Access Dysfunction: A Review.
PubMed 文献 · Ann Vasc Surg · 2017-05-04

该综述回顾至2016年3月的文献,评估外科、放射及药物方法对动静脉内瘘和人工血管移植物成熟、功能维持及功能障碍预防的作用。证据多为小型观察性和回顾性研究,变异较大;早期穿刺移植物、生物移植物及生物性血管周围治疗等新方法可能改善通路功能。

要点

  • 维持通路功能涉及外科、放射和药物多种技术。
  • 早期穿刺移植物和生物移植物是新兴外科方法。
  • 现有证据多为小型观察性和回顾性研究。

核心结论

  • 维持通路功能的策略证据变异较大,许多为小型观察性和回顾性研究。
  • 更广泛使用早期穿刺移植物、杂交手术和血管内操作,以及进一步研究生物移植物和生物性血管周围治疗,可能改善通路功能。

研究设计与样本

  • 综述文献至2016年3月,检索外科、放射和药物方法改善动静脉内瘘和人工血管移植物成熟、维持功能及预防功能障碍的报告。

主要发现

  • 通路功能与内瘘和移植物的构型及吻合技术相关。
  • 新外科方法包括使用早期穿刺移植物和生物移植物。
  • 术前放射血管测绘和通路监测已被研究,狭窄或血栓形成后血管内溶栓、血栓切除、血管成形和支架置入常用。
  • 药物试验包括抗血小板药、ACE抑制剂、他汀、血管周围治疗及其他新药靶点。

临床怎么用

  • 临床上可考虑术前放射血管测绘和通路监测,狭窄或血栓形成时采用血管内管理技术。
  • 药物方面抗血小板药、ACE抑制剂和他汀等可用于试验性维护通路功能。
  • 新兴方法如早期穿刺移植物、杂交手术和生物移植物可能改善通路功能。

局限性

  • 证据多为小型观察性和回顾性研究,变异较大。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current Renal Association guidelines recommend the creation of an arteriovenous fistula as the first choice for hemodialysis access, with artificial grafts kept in reserve. However, maintaining working access comes with significant difficulties, as well as an estimated annual cost to the National Health Service of greater than £84 million. Multiple methods of improving the successful creation of hemodialysis access, improving access maintenance and preventing access dysfunction therefore exist. The aim was to review these methods, including surgical, radiological, and pharmacological techniques. METHODS: The literature was reviewed up to March 2016 for reports of surgical, radiological, and pharmacology approaches to improve maturation, maintain function, and prevent dysfunction of arteriovenous fistulas and artificial access grafts. RESULTS: Access function has been related to fistula and graft configuration and anastomotic technique. Novel surgical approaches include the use of early-cannulation grafts and biological grafts. Preoperative radiological vessel mapping and access surveillance have both been studied, and once stenosis or thrombosis has occurred, endovascular management techniques for thrombolysis and thrombectomy, along with angioplasty and stenting, are common. Pharmacological trials include the use of antiplatelets, ACE inhibitors, statins, along with perivascular therapies, and other more novel drug targets. CONCLUSIONS: The evidence for the strategies that can be used to maintain access function is highly variable, with many small, observational, and retrospective studies. In the future, the more widespread use of early cannulation grafts, hybrid surgical and endovascular procedures, and the further pursuit of both biological grafts and biological perivascular therapies may yield improvements in vascular access function.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Thomas M, Nesbitt C, Ghouri M, et al. Maintenance of Hemodialysis Vascular Access and Prevention of Access Dysfunction: A Review. Ann Vasc Surg. 2017. PMID: 28478166. doi:10.1016/j.avsg.2017.02.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。